Stuart A. Arbuckle, EVP, COO: Vertex Pharmaceuticals VRTX Sell · Filed 23/02/28

Trade details

Type: Insider sale
Amount: $1,100,971.44
Shares · price: 3,834 sh · $287.16 a share
Held after: 57,756 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Stuart A. ArbuckleEVP, COO
Trade date: 23/02/27
Filed: 23/02/28
Days to filing: 1 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/28~23/03/29

Stuart A. Arbuckle's recent trades

Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$29.7K
69 sh
$29.7K
Filed 24/05/17
Traded 24/05/15
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.1M
5,034 sh
$2.1M
Filed 24/02/27
Traded 24/02/26
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.5M
3,603 sh
$1.5M
Filed 24/02/23
Traded 24/02/21
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2M
4,804 sh
$2M
Filed 24/02/21
Traded 24/02/20
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.8M
4,295 sh
$1.8M
Filed 24/02/13
Traded 24/02/12